Skip to main content

Table 2 Parturient characteristics across the four parturient groups

From: Efficacy of continuous in-wound infusion of levobupivacaine and ketorolac for post-caesarean section analgesia: a prospective, randomised, double-blind, placebo-controlled trial

Characteristic

Levobupivacaine alone (n = 15)

Ketorolac tromethamine alone (n = 15)

Combination (n = 14)

Saline placebo (n = 15)

p-value

Age (years)

28.1 ± 2.92 a

31.7 ± 5.11

28.8 ± 5.01

32.5 ± 3.91 a

0.014a (levobupivacaine vs saline placebo)

Weight at conception (kg)

62.0 ± 10.71

59.4 ± 6.81

64.0 ± 8.56

64.1 ± 5.74

ns

Weight at caesarean section (kg)

74.9 ± 11.50

74.7 ± 9.18

80.2 ± 8.93

79.0 ± 7.60

ns

Height (cm)

167.5 ± 6.06

166.1 ± 4.91

166.5 ± 5.97

165.9 ± 4.22

ns

Body mass index at conception (kg/m2)

21.9 ± 3.42

21.2 ± 2.34

22.8 ± 2.46

23.1 ± 2.34

ns

Body mass index at caesarean section (kg/m2)

26.7 ± 3.78

27.1 ± 3.09

28.9 ± 2.27

28.7 ± 3.20

ns

Gestational age (weeks)

38 6/7 ± 0.71 a

38 6/7 ± 0.80

38 5/7 ± 0.67

39 2/7 ± 0.71 a

0.012a (levobupivacaine vs saline placebo)

  1. Data are means ±SD; asignificant difference among groups calculated using ANOVA/Kruskal Wallis test and post-hoc test with Bonferroni correction; ns: non-significant; significant differences are marked with bold text